Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous-cell Carcinoma
Author:
Publisher
Elsevier BV
Subject
Dermatology,Oncology
Reference41 articles.
1. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012;Karia;J Am Acad Dermatol,2013
2. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study;Brantsch;Lancet Oncol,2008
3. Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome;Joseph;Aust N Z J Surg,1992
4. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin;Kwan;Int J Radiat Oncol Biol Phys,2004
5. Cisplatin and cetuximab treatment for metastatic cutaneous squamous cell carcinoma: a systematic review;Trodello;Dermatol Surg,2017
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report;Immunotherapy;2022-12
2. Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma;Future Oncology;2021-02
3. Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?;International Journal of Molecular Sciences;2020-12-06
4. Current evidence for safety and efficacy of anti–programmed cell-death 1 agents in the treatment of cutaneous squamous cell carcinoma: A systematic review;Journal of the American Academy of Dermatology;2020-02
5. Fortgeschrittene Basalzell- und Plattenepithelkarzinome der Haut;best practice onkologie;2019-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3